salmeterol xinafoate has been researched along with Rhinitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babineau, DC; Bacharier, LB; Busse, WW; Cohen, RT; Gergen, PJ; Gern, JE; Gruchalla, RS; Hu, JW; Kercsmar, CM; Khurana Hershey, GK; Kim, H; Lamm, CI; Liu, AH; Makhija, MM; Pillai, D; Sigelman, SM; Togias, A; Wang, E; Wood, RA | 1 |
Chipps, B | 1 |
2 other study(ies) available for salmeterol xinafoate and Rhinitis
Article | Year |
---|---|
Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Anti-Allergic Agents; Asthma; Bronchodilator Agents; Child; Female; Fluticasone; Humans; Male; Phenotype; Prevalence; Rhinitis; Salmeterol Xinafoate; Severity of Illness Index | 2019 |
Systemic reaction to omalizumab.
Topics: Acetates; Adrenal Cortex Hormones; Aged; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Asthma; Cyclopropanes; Depression; Drug Hypersensitivity; Drug Therapy, Combination; Epinephrine; Female; Humans; Hypersensitivity; Hypertension; Methylprednisolone; Omalizumab; Quinolines; Rhinitis; Salmeterol Xinafoate; Seizures; Sulfides; Syncope | 2006 |